Guggenheim Initiates Coverage On BrightSpring Health with Buy Rating, Announces Price Target of $81

Benzinga Newsdesk www.benzinga.com Positive 58.1%

Neg 0% Neu 0% Pos 58.1%

Guggenheim analyst Jason Cassorla initiates coverage on BrightSpring Health (NASDAQ:BTSG) with a Buy rating and announces Price Target of $81.